Zhixiong Zhu
State Key Laboratory Of Biotherapy And Cancer Center
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
YMN-V115: a novel humanized BCMA/GPRC5D/CD3 trispecific antibody in relapsed/refractory multiple myeloma.
Journal: Journal for immunotherapy of cancer
Published: February 04, 2026
A novel CLDN6 nanobody-based bispecific T-cell engager delivered by self-amplifying RNA platform exhibits potent antitumor efficacy.
Journal: Journal of nanobiotechnology
Published: November 26, 2025
Combination of Vaccine With IL-12-Armed Oncolytic Virus SKV-012 Synergistically Potentiates Immune Responses in HPV-Associated Malignancies.
Journal: MedComm
Published: June 04, 2025
A fc-engineered NKG2D × B7-H3 bispecific antibody enhances the antitumor activity by orchestrating cytotoxic lymphocytes.
Journal: International immunopharmacology
Published: January 01, 2025
Myeloid-derived suppressor cell-targeted virus-like particles synergistically activate innate immune response for cancer immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 24, 2024
A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity.
Journal: Cell reports. Medicine
Published: August 05, 2024
CRISPR/Cas9-engineered universal CD123/B7-H3 tandem CAR-T cell for the treatment of acute myeloid leukemia.
Journal: Chinese medical journal
Published: June 13, 2024
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody-Drug Conjugate for Enhanced Antitumor Efficacy in Solid Tumors.
Journal: Molecular cancer therapeutics
Published: May 08, 2024
Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: February 27, 2024
mRNA-Engineered CD5-CAR-γδTCD5- Cells for the Immunotherapy of T-Cell Acute Lymphoblastic Leukemia.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 02, 2024
BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma.
Journal: Journal of nanobiotechnology
Published: November 15, 2023
Last Updated: 09/26/2026